Goldman Sachs
MCRB icon

Goldman Sachs’s Seres Therapeutics MCRB Stock Holding History

Goldman Sachs’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,500
Closed -$172K – 6432
2022
Q2 		$172K Hold
2,500
– – ﹤0.01% 5694
2022
Q1 		$356K Buy
+2,500
New +$385K ﹤0.01% 5556
2020
Q4 		– Sell
-24,450
Closed -$13.8M – 5613
2020
Q3 		$13.8M Buy
+24,450
New +$8.13M ﹤0.01% 2042
2016
Q2 		– Sell
-1,750
Closed -$930K – 7154
2016
Q1 		$930K Hold
1,750
– – ﹤0.01% 4132
2015
Q4 		$1.23M Sell
1,750
-375
-18% -$246K ﹤0.01% 4095
2015
Q3 		$1.26M Buy
+2,125
New +$1.73M ﹤0.01% 4244

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return